本页面由Tiger Trade Technology Pte. Ltd.提供服务

POINT BIOPHARMA GLOBAL INC

12.50
0.0000
成交量:- -
成交额:4,112.71万
市值:13.32亿
市盈率:13.92
高:12.50
开:12.50
低:12.50
收:12.50
52周最高:14.35
52周最低:6.39
股本:1.07亿
流通股本:7,003.28万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):0.8979
每股收益(LYR):1.04
净资产收益率:26.33%
总资产收益率:16.77%
市净率:3.14
市盈率(LYR):12.03

数据加载中...

2023/12/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/12/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/12/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/12/27

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/12/27

重要事件披露

Form 8-K - Current report
2023/12/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/10/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/14

重要事件披露

Form 8-K - Current report
2023/06/06

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals